U UNI-QLEAVER
LIVE

Serial Number

79271602

Owner

QuiaPEG Pharmaceuticals AB

Attorney

Cynthia Johnson Walden

Filing Date

Sep 2, 2019

Add to watchlist:

No watchlists yet
View on USPTO

U UNI-QLEAVER Trademark

Serial Number: 79271602 • Registration: 6177161

U UNI-QLEAVER is a trademark filed by QuiaPEG Pharmaceuticals AB on September 2, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

QuiaPEG Pharmaceuticals AB (4 trademarks)

Virdings Allé 32 B
Uppsala SE-754 50 , SE

Entity Type: 03

Trademark Details

Filing Date

September 2, 2019

Registration Date

October 20, 2020

Published for Opposition

August 4, 2020

Goods & Services

Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances; PEGylation pharmaceuticals research services; industrial analysis and industrial research services in the field of pharmaceutical testing; product design, testing and development in the field of medical technology; information and advice regarding the aforementioned services

Chemicals for use in industry and science; biological preparations for use in industry and science; Reagents for scientific and research use, Diagnostic preparations for scientific or research use; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers

Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; reagents for medical and veterinary uses; pharmaceutical substances being diagnostic, preparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents, substances and contrast media for medical and veterinary purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 20, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 3, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 20, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 1, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 1, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 1, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 1, 2020 CNEA
EXAMINER'S AMENDMENT ENTERED
May 26, 2020 XAEC
ASSIGNED TO LIE
May 26, 2020 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 26, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 26, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 26, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2020 TROA
REFUSAL PROCESSED BY IB
Jan 17, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 1, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 31, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 5, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 19, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 14, 2019 REPR